Central adiposity increases the risk for urinary incontinence, finds study

According to a recent study conducted at the University of Jyväskylä, Finland, body composition is associated with symptoms of pelvic floor disorders in middle-aged women. Larger fat mass increases the risk of stress urinary incontinence. The risk factors include larger fat mass, especially in the waist area and around visceral organs, as well as larger waist circumference and body mass index.
Read More

Alzheimer’s disease research offers hope for finding therapeutic target that stops progression

In searching for a possible therapeutic target to stop the progress of this disease, an international scientific team, led by researchers at the Department of Cell Biology, Genetics and Physiology of the UMA and also members of the Baglietto lab and the NeuroAD research group, has identified different factors involved in the propagation processes.
Read More

Alzheimer’s disease research offers hope for finding therapeutic target that stops progression

In searching for a possible therapeutic target to stop the progress of this disease, an international scientific team, led by researchers at the Department of Cell Biology, Genetics and Physiology of the UMA and also members of the Baglietto lab and the NeuroAD research group, has identified different factors involved in the propagation processes.
Read More

The quest to reinvent anesthesia

Before 1846, surgery was a crude and brutal undertaking, typically performed on conscious patients lashed to their beds. Then a Boston dentist publicly demonstrated that the highly flammable chemical diethyl ether—commonly called ether—could render a patient unconscious and insensitive to pain. Overnight, surgery became a major player in modern medicine.
Read More

Mediterranean, fasting or DASH? Exploring promising metabolic benefits for management of MASLD

Imagine a condition affecting nearly one-third of the global population, often silently progressing, and deeply intertwined with prevalent health issues like obesity and type 2 diabetes. This is metabolic dysfunction-associated steatotic liver disease, or MASLD, previously known as non-alcoholic fatty liver disease (NAFLD). It’s characterized by an excessive accumulation of fat in the liver, which can lead to more severe liver pathologies, including inflammation, fibrosis, and even liver cancer.
Read More
Top